Celularity Company
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.
Investors
Technology:
COVID
Industry:
CAR-T
Headquarters:
Florham Park, New Jersey, United States
Founded Date:
2017-09-01
Employees Number:
N/A
Funding Status:
IPO
Investors Number:
12
Total Funding:
370000004
Estimated Revenue:
$50M to $100M
Last Funding Date:
2021-07-19
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership